Repeated Dosing Clinical Trial of HL151

Clinical trial NCT02686294 · COMPLETED

Trial details

NCT number: NCT02686294
Sponsor: Hanlim Pharm. Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Rhinitis, Allergic, Perennial

Start date: 2016-02-16
Primary completion: 2016-03-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.